FDA plans to put “black box” warning on Covid vaccines
Digest more
Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several ...
Food and Drug Administration commissioner Martin Markary speaks during an event in the Roosevelt Room at the White House, Monday, May 12, 2025, in Washington. (AP Photo/Mark Schiefelbein) WASHINGTON ...
Novavax COVID vaccine trial participants left battling a tough decision after FDA submission delayed
Novavax recently announced that it would delay its timeline for seeking U.S. authorization for its two-dose COVID-19 vaccine. This leaves thousands of Novavax trial participants stranded when it ...
Shares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4 billion deal with Sanofi to commercialize its Covid vaccine and develop a new combination shot ...
A medical worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax at the Tegel vaccination center on February 28, 2022 in Berlin, Germany. This story was originally published ...
The U.S. Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could be available by the end of next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback